[Effect of Verapamil on the glycogen-phosphorylase system of rats].
D000410:Alanine Transaminase / Q000097:blood / Q000378:metabolism; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001219:Aspartate Aminotransferases / Q000097:blood / Q000378:metabolism; D003864:Depression, Chemical; D005947:Glucose / Q000032:analysis; D006003:Glycogen / Q000032:analysis; D006600:Hexosephosphates / Q000032:analysis; D066298:In Vitro Techniques; D007770:L-Lactate Dehydrogenase / Q000097:blood / Q000378:metabolism; D007931:Leucyl Aminopeptidase / Q000097:blood / Q000378:metabolism; D008099:Liver / Q000032:analysis / Q000201:enzymology*; D008297:Male; D009206:Myocardium / Q000032:analysis / Q000201:enzymology*; D009570:Nitriles / Q000494:pharmacology*; D009928:Organ Specificity; D013268:Stimulation, Chemical; D014665:Vasodilator Agents / Q000494:pharmacology*
D000889:Anti-Arrhythmia Agents; D006600:Hexosephosphates; D009570:Nitriles; D014665:Vasodilator Agents; D006003:Glycogen; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D007931:Leucyl Aminopeptidase; D005947:Glucose
Der Einfluss von Verapamil auf das Glykogen-Phosphorylasesystem von Ratten.